January 18, 2016
HIT Consultant
Authored by Aaron J. Capron and Robert D. Wells
One of the fastest growing segments of startups is digital health startups, creating cutting-edge innovations that improve the management and operations of hospitals and clinical practices, and the effectiveness of patient care. Given the steady increase in competition in this field and the need for startups to obtain venture capital funding, these digital-health companies should protect their innovations through intellectual property.
But many obstacles hinder the acquiring of such protection. On the business side, startups have limited resources and are preoccupied by the huge day-to-day essential efforts of starting the new company. On the legal side, recent federal court decisions and corresponding U.S. Patent and Trademark Office (USPTO) policies have made acquiring protection for certain types of software-related technologies more difficult to obtain. Facing these obstacles, digital-health companies can struggle to develop meaningful protection for their innovations.
Despite these obstacles, digital-health companies can implement strategies for developing an effective intellectual property portfolio to cover its innovations, a few of which are listed below.
Startups usually face budget constraints and evolving products and technologies that make it expensive to pursue protection for each innovation. But performing an invention audit to identify all innovations in use or in development can direct and help startups determine which innovations warrant IP protection. After identifying each innovation, companies can then score innovations according to criteria like:
(1) Whether the innovation provides a competitive advantage;
(2) How different the innovation is from known practices;
(3) The ease of reverse engineering the innovation;
(4) The ability to detect whether competitors copy the innovation; and
(5) The value of the innovation to competitors, business partners, or possible licensees.
Using these scores, the companies derive a cumulative score for each innovation, compare the values of its innovations, and pursue patent protection for those with the highest cumulative scores. Startups can protect lower scoring innovations as trade secrets or not protect them at all.
Along with technical innovations, digital-health companies often make considerable investments in the design of its products, including the user interfaces, screens, icons, fonts, animations, and other enhancements for the overall appearance of their products. These companies should consider protecting the look and feel of its products using design patents.
Protecting both the design and the underlying technology of the product provides companies with the opportunity to protect the overall user experience of a product. The cost of acquiring a design patent is also usually an order of magnitude less than the cost of a typical utility patent.
Many patent applications filed today focus on content, potentially causing problems. They focus on the data used (e.g., healthcare-related-data)—as opposed to the underlying technology that processes the data.
Focusing on content could make it substantially harder to get an issued patent. When it's filed, the USPTO determines which technology area an application belongs in. As shown in the chart below, this classification can significantly affect the probability of obtaining a patent. The likelihood of obtaining a patent for applications classified as ecommerce plummets from between 60-75%, to below 10%.
Digital-health startups should take note since the USPTO classifies some digital-health applications to its ecommerce group. To avoid this problem the specification and claims should focus on the underlying technology—rather than the content being handled by the product. While there's no way to guarantee a technology classification, this method can dramatically increase the likelihood that the application is assigned to a more patent-friendly technology area.
Another effective strategy for preserving patent rights is to file an "omnibus patent application"—a single utility patent application that discloses multiple innovations of a product (click here for an example). Omnibus applications claim one disclosed innovation, and continuation applications claim the others.
Omnibus patent applications provide digital-health companies with more flexibility than typical "single innovation" applications, allowing them to pursue claims that cover multiple functionalities—possibly even a competitor's forthcoming products—as products are developed in the quickly evolving digital-health marketplace.
These are just a few possible strategies to consider. These and other strategies can be tailored to help develop successful growth businesses, protecting a digital health startup's R&D investments.
Originally printed in HIT Consultant. This article is for informational purposes, is not intended to constitute legal advice, and may be considered advertising under applicable state laws. This article is only the opinion of the authors and is not attributable to Finnegan, Henderson, Farabow, Garrett & Dunner, LLP, or the firm's clients.
Conference
Boston Intellectual Property Law Association 4th Annual Symposium
April 10-11, 2024
Boston
Conference
Best Practices in Intellectual Property– A Decade of Dedication to IP Excellence
April 8-9, 2024
Tel Aviv
Lecture
IP (Intellectual Property) Due Diligence & Freedom to Operate in Practice Training Course
March 7-8, 2024
Virtual
Hybrid Seminar
Intellectual Property and International Dispute Resolution
February 23, 2024
Washington
At the PTAB Blog
February 6, 2024
Hybrid Seminar
Intellectual Property Law Pragmatic Combat High-Level Talent Training Course
December 2, 2023
Taipei City
Lecture
Drafting International Intellectual Property Agreements Training Course
November 16, 2023
London
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.